These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 16410812

  • 21. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH.
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [Abstract] [Full Text] [Related]

  • 22. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
    Duh EJ, Yang HS, Haller JA, De Juan E, Humayun MS, Gehlbach P, Melia M, Pieramici D, Harlan JB, Campochiaro PA, Zack DJ.
    Am J Ophthalmol; 2004 Apr; 137(4):668-74. PubMed ID: 15059706
    [Abstract] [Full Text] [Related]

  • 23. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C, Segura RM, Fonollosa A, Carrasco E, Francisco G, Simó R.
    Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
    [Abstract] [Full Text] [Related]

  • 24. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
    Funatsu H, Yamashita H, Sakata K, Noma H, Mimura T, Suzuki M, Eguchi S, Hori S.
    Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
    [Abstract] [Full Text] [Related]

  • 25. [A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy].
    Zhou H, Zhang H.
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):247-50. PubMed ID: 10451953
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage.
    Descamps FJ, Martens E, Kangave D, Struyf S, Geboes K, Van Damme J, Opdenakker G, Abu El-Asrar AM.
    Exp Eye Res; 2006 Aug; 83(2):401-7. PubMed ID: 16643893
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy.
    Zhou J, Wang S, Xia X.
    Curr Eye Res; 2012 May; 37(5):416-20. PubMed ID: 22409294
    [Abstract] [Full Text] [Related]

  • 30. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
    Kon CH, Occleston NL, Aylward GW, Khaw PT.
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy.
    Petrovic MG, Korosec P, Kosnik M, Hawlina M.
    Am J Ophthalmol; 2007 Jan; 143(1):175-6. PubMed ID: 17188064
    [Abstract] [Full Text] [Related]

  • 33. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
    Mohan N, Monickaraj F, Balasubramanyam M, Rema M, Mohan V.
    J Diabetes Complications; 2012 Jan; 26(5):435-41. PubMed ID: 22699109
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
    Fosmark DS, Bragadóttir R, Stene-Johansen I, Berg JP, Berg TJ, Lund T, Sandvik L, Hanssen KF.
    Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
    [Abstract] [Full Text] [Related]

  • 37. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy.
    Kauffmann DJ, van Meurs JC, Mertens DA, Peperkamp E, Master C, Gerritsen ME.
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):900-6. PubMed ID: 8125753
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin.
    Funatsu H, Yamashita H, Noma H, Mochizuki H, Mimura T, Ikeda T, Hori S.
    Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1042-7. PubMed ID: 12601027
    [Abstract] [Full Text] [Related]

  • 40. Comparison of vitreous and plasma levels of vascular endothelial growth factor, interleukin-6 and hepatocyte growth factor in diabetic and non-diabetic retinal detachment cases.
    Kocak N, Alacacioglu I, Kaynak S, Ozcan MA, Celik O, Yuksel F, Piskin O, Oner H, Saatci AO, Ergin M.
    Ann Ophthalmol (Skokie); 2010 Mar; 42 Spec No():10-4. PubMed ID: 21138144
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.